ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

October 19, 2005  Sell to close the General Electric December 32.50 call option (GE + LZ) for a loss of about 30 percent.  General Electric (GE) reported solid third quarter earnings last Friday. The company's revenue expanded by a healthy 9 percent to $41.9 billion in the period.  Read More

October 11, 2005  Buy to open the EnCana (ECA) January 55 call option (ECA +AK) at the market. Oil prices were under pressure on fears that demand is lessening in the wake of the high prices that have prevailed in recent months.  Read More

Buy to open the Philadelphia Gold/Silver Index (XAU) December 110 call option (XAV +LB). Pay no more than $6.40 for the call.   Virtually every measure of inflation is accelerating right now. And all evidence points to it getting worse as we move forward.  Read More

Buy to close the ExxonMobil January 60 put option (XOM + ML) you previously wrote (sold) for about 50 percent loss.   Energy stocks across the board have come under intense selling pressure due to fears that demand is tapering off.  Read More

October 6, 2005  Buy to open the EnCana January 50 Call option (ECA +AK) at the market. Oil prices fell to their lowest levels in two months today on fears that demand is lessening in the wake of the high prices that have prevailed in recent months.  Read More

Sell to Close the Amylin Pharmaceuticals April 30 call option (AQM + DF) and Buy to Open the Amylin April 40 call option (AQM + DH) in its place. Place both trades at the market.  Amylin Pharmaceuticals (AMLN) Read More

Sell to close the Genentech January 85 (DWN + AQ) call option at the market for a gain of 25 percent in just four days.   Genentech (DNA) is a great growth stock, but given its lofty valuations it's prone to wide price swings.  Read More